Anyone who tells you anything definitive about what CBD — or THC, for that matter — does to your body is lying. Nobody knows. The legitimate research out there is extremely limited, and the slow drip of legalization — medical use, then personal use, federally illegal but permitted by certain states and cities — has made it incredibly hard for researchers to do their jobs.
A study analysis in Journal of Pain Research confirms that topical use of certain cannabinoid topicals can reduce pain in animals with inflammation or neuropathic pain. And science has found topical creams with THC and CBD help relieve pain for conditions like multiple sclerosis. But for the vast majority of chronic pain—and most certainly for acute pain like post-workout—the scientific jury is 100 percent still out. "There's a little bit of data in support of CBD for pain relief, but to go from animal to human is a giant leap," Sexton says.
Return Policy: Once order has been received and you are not satisfied with the product within 30 days of purchase you may return for full refund. Any manufacturer defects or issues on the part of the manufacturer, you may return for a replacement or refund within 30 days of purchase. Pricing and specials are subject to change. Please reach out to your Rep or Sales Manager with any questions regarding the product. Please be aware that the products may contain essential oils and infused herbs, therefore if you have any allergies to such please do not use.
Prescription medicine (Schedule 4) for therapeutic use containing 2 per cent (2.0%) or less of other cannabinoids commonly found in cannabis (such as ∆9-THC). A schedule 4 drug under the SUSMP is Prescription Only Medicine, or Prescription Animal Remedy – Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription.
A quality CBD topical cream provides the advantage of being able to apply the active therapeutic hemp extract directly to the site of aggravation or discomfort. This is particularly useful for application to joint areas or superficial muscle tissue, as the cannabidiol compound will diffuse across the dermal layers directly to the site of pain and inflammation.
Hi Kim — I hope you have found some relief over the past three months since you posted. I am 27 and have already been through four foot surgeries for arthritis, and will be having my hip operated on next month. I’ve tried everything over the last 8 years since this all started, and deal with a lot of the same issues you described (very poor sleep, limited mobility, etc.).
I live in BC Canada and the same thing is happening here. I am aligned with an amazing US hemp based CBD oil company. We now need a prescription to get the Hemp CBD in Canada yet I can walk into any medical marijuana shop w/o a prescription and get any type of medical marijuana product no problem. We will be legal for recreational use in Oct but need an Prescription for Hemp based. It’s ridiculous. Must be about who gets to make $.
Determining risks and benefits through proper clinical trials remains highly desired, but these will take considerable time and funds. As a result, clinical data will not appear any time soon, while patients will not simply stop using the many CBD products to which they have become accustomed. Taking back regulatory control over CBD could therefore start with a more short-term and achievable approach, i.e., demanding accurate and proper labeling, reflecting in detail what each product does and does not contain, and how it was manufactured. For a clearer judgment of the potential therapeutic effects, the risks, but also the legality of a cannabis extract, it is important to know its exact composition. After all, published data from around the world has taught us that misleading labels as well as harmful contaminants are real and actual problems for CBD products. The analytical methodology and the third-party labs needed for this approach largely already exist, and could easily be optimized to quickly get a better grip on the unrestrained cannabinoid market. This approach would hold each producer strictly accountable for the quality and safety of their own products, as long as there are real legal consequences for those businesses that break the rules. Add to this a system for regular professional audits and inspections, and a crackdown on unsubstantiated health claims, and we have a reasonable system to ensure that CBD can be used responsibly by those who need it, until much needed clinical data become available.
SteepFuze Hemp Cannabinoid Coffee – Spring Release Spring Release begins with Ethiopian Yirgacheffe, one of the most popular beans in the coffee world, sourced from the mountains of the Sidama region of southern Ethiopia. Spring Release beans are delicately roasted to a medium level to preserve the natural sugars and sweetness. The beans are infused with […]
Our reviews also include the ingredients and a description of the scent and texture of each CBD topical. We tried to remain neutral in our descriptions of each product, since each consumer’s experience is subjective. These are all high-quality CBD creams, balms and salves, but you may find you prefer one scent over another. You might love or hate menthol. Some people prefer a light texture, while other buyers are looking for CBD topicals to use in a massage.
Cannabis, on the other hand, was grown for many generations for medical and recreational purposes, so the genetic aspects of the plant that have survived and evolved are different. The cannabinoids, terpenes, and strength of the different parts of the plant have been bred to induce different effects in people or help solve medical issues, whether skin conditions, epilepsy, or others.
CBD has noted effects on many systems the brain uses to send signals to your body. One of these is the endocannabinoid system. When used, CBD can have beneficial effects on people who suffer neurological disorders. The research in this area is still new. However, there were many studies where CBD was tested for its effect on treating MS and epilepsy.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.